Weight loss improves endothelial function independently of ADMA reduction in severe obesity

Hormone and Metabolic Research

Volumn 43, Issue 5, 2011, Pages 343-348

  Rudofsky, G ^a   Roeder, E ^a,b   Merle, T ^a   Hildebrand, M ^a   Nawroth, P P ^a   Wolfrum, C ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ETH ZURICH   (Switzerland)

Author keywords

ADMA; endothelial dysfunction; obesity; pulse wave analysis; siCAM; weight loss

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYMPHOCYTE ANTIGEN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; SALBUTAMOL; SOLUBLE INTERCELLULAR ADHESION MOLECULE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CELL ADHESION; CHEMICAL PARAMETERS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ENDOTHELIAL DYSFUNCTION; FEMALE; FUNCTION TEST; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LOW CALORY DIET; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE ANALYSIS; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ARGININE; BODY MASS INDEX; CALORIC RESTRICTION; CELL ADHESION MOLECULES; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS; YOUNG ADULT;

EID: 79955723755     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1271778     Document Type: Article

References (35)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1998; 334: 1349-1357
2. Bray GA, Clearfield MB, Fintel DJ, Nelinson DS. Overweight and obesity: the pathogenesis of cardiometabolic risk. Clinical Cornerstone 2009; 9: 30-42
3. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management. Nutr Metab Cardiovasc Dis 2010; 20: 140-146
4. Hashimoto M, Akishita M, Eto M, Kozaki K, Ako J, Sugimoto N, Yoshizumi M, Toba K, Ouchi Y. The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes 1998; 22: 477-484 (Pubitemid 28211977)
5. Arkin JM, Alsdorf R, Bigornia S, Palmisano J, Beal R, Istfan N, Hess D, Apovian CM, Gokce N. Relation of cumulative weight burden to vascular endothelial dysfunction in obesity. Am J Cardiol 2008; 101: 98-101 (Pubitemid 350297207)
6. Fuchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376 (Pubitemid 11169009)
7. Rudofsky G Jr, Reismann P, Grafe IA, Konrade I, Djuric Z, Tafel J, Buchbinder S, Zorn M, Humpert PM, Hamann A, Morcos M, Nawroth PP, Bierhaus A. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity. Horm Metab Res 2007; 39: 665-671 (Pubitemid 47492650)
8. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601-2610
9. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Caselli A, Caballero AE, Economides PA, Veves A, Horton ES. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003; 26: 2119-2125 (Pubitemid 41184262)
10. Sciacqua A, Candigliota M, Ceravolo R, Scozzafava A, Sinopoli F, Corsonello A, Sesti G, Perticone F. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003; 26: 1673-1678 (Pubitemid 36929102)
11. Brook RD. Obesity, weight loss, and vascular function. Endocrine 2006; 29: 21-25 (Pubitemid 43780343)
12. McLaughlin T, Stühlinger M, Lamendola C, Abbasi F, Bialek J, Reaven GM, Tsao PS. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. J Clin Endocrinol Metab 2006; 91: 1896-1900
13. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999; 43: 542-548 (Pubitemid 29369253)
14. Marliss EB, Chevalier S, Gougeon R, Morais JA, Lamarche M, Adegoke OA, Wu G. Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover. Diabetologia 2006; 49: 351-359 (Pubitemid 43185404)
15. Boeger RH. Asymmetric dimethylarginine (ADMA): A novel risk marker in cardiovascular medicine and beyond. Ann Med 2006; 38: 126-136
16. Closs EI, Basha FZ, Habermeier A, Förstermann U. Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1997; 1: 65-73 (Pubitemid 28078129)
17. Azuma H, Sato J, Hamasaki H, Sugimoto A, Isotani E, Obayashi S. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br J Pharmacol 1995; 115: 1001-1004
18. Jang JJ, Ho HK, Kwan HH, Fajardo LF, Cooke JP. Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation 2000; 102: 1414-1419
19. Boeger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Boeger SM. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S- adenosylmethionine- dependent methyltransferases. Circ Res 2000; 87: 99-105 (Pubitemid 30616904)
20. Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola- Klein C, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, Muenzel T. Asymmetric Dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease. Circ Res 2005; 97: e53-e59
21. Boeger RH, Bode-Boeger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847 (Pubitemid 28509278)
22. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, Kruszelnicka-Kwiatkowska O, Kokot F, Dubiel JS, Froelich JC. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 1999; 33: 652-658 (Pubitemid 29164831)
23. Krzyzanowska K, Mittermayer F, Kopp HP, Wolzt M, Schernthaner G. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab 2004; 89: 6277-6281 (Pubitemid 39628445)
24. Konukoglu D, Uzun H, Firtina S, Cigdem Arica P, Kocael A, Taskin M. Plasma adhesion and inflammation markers: asymmetrical dimethyl- L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg 2007; 17: 672-678 (Pubitemid 46950641)
25. Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, Shu YE, MacKay LS, Webb DJ, Cockcroft JR. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147-152 (Pubitemid 34076246)
26. Sourij H, Zweiker R, Wascher TC. Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes. Diab Care 2006; 29: 1039-1045 (Pubitemid 44115241)
27. Woodman RJ, Watts GF. Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus. Med Sci Monit 2003; 9: RA81-RA89
28. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, Poole- Wilson PA, Ertl G, Bauersachs J. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 2005; 46: 1693-1701 (Pubitemid 41531624)
29. Anderssohn M, Schwedhelm E, Lüneburg N, Vasan RS, Böger RH. Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus. Diab Vasc Dis Res 2010; 7: 105-118
30. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113: 1888-1904 (Pubitemid 43739401)
31. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 105: 311-320 (Pubitemid 30094451)
32. Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 2004; 47: 532-536 (Pubitemid 38491250)
33. Suzuki M, Takamisawa I, Yoshimasa Y, Harano Y. Association between insulin resistance and endothelial dysfunction in type 2 diabetes and the effects of pioglitazone. Diabetes Res Clin Pract 2007; 76: 12-17 (Pubitemid 46240368)
34. Marx N, Duez H, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 2004; 94: 1168-1178 (Pubitemid 38656403)
35. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-2155 (Pubitemid 23326094)